相关实验视频

Updated: Jul 18, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

在APP乙化上SIRT1和SIRT2的合作作用

Na Li¹, Ning Bai^2,3, Xiong Zhao^2,3

¹Department of Gerontology and Geriatrics, Shengjing Hospital, China Medical University, Shenyang, China.

|August 21, 2023

概括

阿尔茨海默病涉及粉样蛋白-β. 这项研究表明,SIRT1通过阻断SIRT2对粉样蛋白前体蛋白的作用来保护神经元,从而提供了一个新的阿尔茨海默氏症治疗点.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
衰老研究研究衰老研究

背景情况:

阿尔茨海默病 (AD) 是一种神经退行性疾病,与粉样蛋白β (Aβ) 和病理有关.
依赖NAD+的脱乙酶SIRT1和SIRT2与衰老有关,但它们在AD中的作用尚不清楚.

研究的目的:

为了研究SIRT1和SIRT2在阿尔茨海默氏病的发病过程中的合作作用.
阐明SIRT1和SIRT2影响粉样蛋白前体蛋白 (APP) 处理的分子机制.

主要方法:

在老化和AD小鼠大脑中分析SIRT2:SIRT1比率.
在Aβ挑战下使用HT22小鼠海马神经元细胞的体外研究.
调查SIRT1对Aβ诱导的神经毒性和APP脱乙化的影响.
评估SIRT1在APP贩运和处理中的作用.

主要成果:

在老化和AD小鼠大脑中,SIRT2:SIRT1比率升高.
通过Aβ挑战,SIRT1降低,而SIRT2在神经元细胞中的表达增加.
过度表达SIRT1可对Aβ毒性产生神经保护作用.
SIRT1 抑制了 SIRT2 与 APP 的结合,防止了 APP 的脱乙化.
删除SIRT1通过改变其细胞贩运来促进APP的氨基原性加工.

结论:

通过抑制SIRT2介导的APP脱乙化,SIRT1可以防止AD的神经毒性.
这种机制突显了SIRT1在调节APP处理和神经元存活方面的作用.
准SIRT1-SIRT2相互作用为阿尔茨海默病提供了潜在的治疗策略.

关键词:

这就是为什么APP APP APP.阿尔茨海默病的疾病阿尔茨海默病的疾病.一个SIRT1系统.在SIRT2中,SIRT2是SIRT2.老化的老化衰老的老化粉样化物-β-β 的存在.氨基胺基的加工加工.脱乙化脱乙化

更多相关视频

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

相关概念视频

Phase II Reactions: Acetylation Reactions

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....